Intel stock price today: INTC slips into New Year holiday as Nvidia stake, earnings loom

Intel stock price today: INTC slips into New Year holiday as Nvidia stake, earnings loom

NEW YORK, January 1, 2026, 19:32 ET — Market closed.

  • Intel shares last closed down 1.1% at $36.90, as U.S. stocks ended 2025 lower in thin holiday trading. StockAnalysis
  • Intel finished 2025 up about 84%, placing it among the S&P 500’s top gainers for the year, MarketWatch data showed. MarketWatch
  • Traders continue to digest Nvidia’s $5 billion equity purchase disclosed in a recent filing. Reuters

Intel shares ended the last U.S. session down 1.1% at $36.90, as Wall Street slipped in the final trading day of 2025. U.S. markets were closed on Thursday for New Year’s Day and reopen on Friday, Jan. 2. StockAnalysis

The pullback matters because Intel heads into 2026 after a sharp rebound that has raised expectations for its turnaround. Intel rose about 84% in 2025, MarketWatch data showed. MarketWatch

Investors have also kept a close watch on fresh capital moving into the company after Nvidia disclosed a $5 billion purchase of Intel shares in a filing on Dec. 29, Reuters reported. Reuters

The broader tape offered little help late in 2025, with the S&P 500 down 0.74% on Dec. 31 and the Nasdaq off 0.76%, Reuters reported. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity, pointing to profit-taking when liquidity was low. Reuters

Nvidia bought about 214.7 million Intel shares at $23.28 each in a private placement — a sale to a select investor rather than the public market — Reuters reported. U.S. antitrust agencies cleared the investment earlier in December, Reuters said. Reuters

The deal deepens ties between Intel and Nvidia, the dominant supplier of AI accelerators, as Intel tries to regain ground in PCs and servers and expand its contract chipmaking business.

Intel’s late-December trade has been choppy. Shares rose 1.3% on Dec. 29 and 1.7% on Dec. 30 before slipping on Dec. 31, when they traded between $36.87 and $37.58. StockAnalysis

Liquidity was thin into year-end. Volume on U.S. exchanges totaled about 11.17 billion shares on Dec. 31 versus a 20-session average of 15.8 billion, Reuters reported. Reuters

Intel’s next major company catalyst is its fourth-quarter report, but the company’s investor relations calendar currently lists no upcoming events. Market calendars point to late January, with Nasdaq estimating an earnings date of Jan. 29. Intel Corporation

When it last reported results in October, Intel forecast fourth-quarter revenue of $12.8 billion to $13.8 billion and non-GAAP earnings per share of $0.08; non-GAAP is an adjusted figure that excludes certain items such as restructuring and other one-time costs. Intel Corporation

Before the next session, investors will parse U.S. data due Friday including weekly initial jobless claims (08:30 ET) and construction spending (10:00 ET), according to the New York Fed’s economic indicators calendar.

Next week brings the ISM manufacturing PMI on Jan. 5, ISM’s release calendar showed; PMI is a survey-based gauge of factory activity. The U.S. jobs report follows on Jan. 9 (08:30 ET), the New York Fed calendar showed.

On charts, traders have been watching the $35 area after the stock’s late-December low of $34.95, while $38 has capped rallies following Tuesday’s $38.26 high. A decisive break could set the tone for INTC as earnings season approaches. StockAnalysis

Stock Market Today

  • Boston Scientific Shows Stock Weakness but Strong ROE and Earnings Growth Signal Potential
    January 22, 2026, 6:32 AM EST. Boston Scientific Corporation (NYSE:BSX) stock has dropped 10% over the last three months, reflecting recent market weaknesses. However, its financials indicate strength with a robust return on equity (ROE) of 12%, above the industry average of 9.8%. ROE, which measures profit generated per shareholder dollar, highlights the company's effective use of capital. Notably, Boston Scientific has achieved a 21% net income growth over five years, outpacing the industry's 12% growth rate. This suggests strong management decisions and potential for long-term value appreciation. Investors should weigh these factors, considering earnings growth as a key valuation metric, to assess if Boston Scientific's current stock price reflects its growth prospects.
Tesla stock ends 2025 lower as Musk charity share gift surfaces ahead of deliveries
Previous Story

Tesla stock ends 2025 lower as Musk charity share gift surfaces ahead of deliveries

Pentagon awards Lockheed $328.5 million Taiwan contract for IR sensor pods as China drills escalate
Next Story

Pentagon awards Lockheed $328.5 million Taiwan contract for IR sensor pods as China drills escalate

Go toTop